Join the Opiate Withdrawal group to help and get support from people like you.
Opiate Withdrawal News (Page 3)
Related terms: Opioid Withdrawal
Trained Peers as Good as Social Workers at Preventing Opioid Overdoses
THURSDAY, July 11, 2024 – Support provided by someone who has personally lived with addiction is an effective way to follow-up with ER patients after an opioid overdose, new research shows. Patients...
Acupuncture Can Reduce Methadone Dose, Opioid Craving
MONDAY, July 8, 2024 – For individuals with opioid use disorder receiving methadone maintenance treatment (MMT), eight weeks of acupuncture is superior to sham acupuncture for reducing methadone...
New Drug Could Boost Lifesaving Powers of Overdose Drug Naloxone
MONDAY, July 8, 2024 – An experimental drug can supercharge the effects of the lifesaving overdose drug naloxone, potentially improving its effectiveness against new and more powerful opioids like...
Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received Them
THURSDAY, June 27, 2024 – Only one-quarter of adults who needed opioid use disorder (OUD) treatment in 2022 received medications for OUD, according to research published in the June 27 issue of the...
Most Outpatient Mental Health Clinics Don't Offer Opioid Addiction Meds
WEDNESDAY, June 19, 2024 – Only a third of outpatient mental health facilities offer medications essential for treating opioid addiction, a new study finds. Standard care for treating people with...
High Out-of-Pocket Costs Keep Some From Lifesaving Opioid Antidote
TUESDAY, June 18, 2024 – Patients are less likely to fill prescriptions for the overdose-reversing drug naloxone when they have to shell out more at the pharmacy, a new study finds. Naloxone (also...
Rapid Procedure Noninferior for Extended-Release Naltrexone Initiation
THURSDAY, May 9, 2024 – For patients with opioid use disorder (OUD), a rapid procedure (RP) is noninferior to a standard procedure for initiation of extended-release (XR) naltrexone, according to a...
Elimination of Buprenorphine Waiver Had Moderate Effect
MONDAY, May 6, 2024 – Elimination of the buprenorphine waiver increased the number of prescribers, but only modestly increased the number of patients in whom buprenorphine treatment was initiated,...
FDA Approves Lucemyra (lofexidine hydrochloride) as the First Non-Opioid Treatment for Management of Opioid Withdrawal Symptoms
May 16, 2018 – The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in...